|
|
|||||||||
![]() |
|||||||||
|
|
|||||||||
![]() |
|||||||||
|
Olaia
Naveiras, M.D., Ph.D. Post-Doctoral Fellow |
|||||||||
|
I
am interested in how the environment provides signalling cues to determine
the hematopoietic stem cell (HSC) fate. During development, HSCs encounter
at least four different niches in the four different sites where they
originate: the yolk sac, the aorta-gonada-mesonephros (AGM), the fetal
liver, and the bone marrow. the Calvi et al. and Zhang et al. have provided
strong evidence in 2003 that the osteoblast provides the niche for HSCs
on the bone marrow. However, the molecules responsible for the osteoblast's
ability to maintain HSCs uncommitted are still to be confirmed. N-cadherin,
Notch1/Jagged2, Tie2/Angiopoietin-1, Frizzled/Wnt, and BMPR-BMP4 molecular
pairs from the osteoblast to the HSC have been implicated (see figure).
Our ability to produce HSCs in vitro from mouse embryonic stem cells in
the context of bone marrow-derived OP9 supportive stroma provides us with
an in vitro surrogate assay to study both the phenotype of the ES-derived
mouse HSC and the molecular interactions necessary for the stroma to induce
HSC's asymmetric divisions.
|
|||||||||
![]() |
|||||||||
|
In
the BM, osteoblasts and endothelium constitute functional niches providing
positive or negative signals for HSC self-renewal. In addition to hematopoietic
cells, endothelial cells, and osteoblasts, adult BM contains numerous
adipocytes. Interestingly, the number of adipocytes correlates inversely
with the gross hematopoietic activity of the marrow. Whether adipocytes
have a direct effect on hematopoietic progenitors or whether they act
as mere space-fillers in this context remains unclear. To determine the
potential role of bone marrow adipocytes in hematopoiesis, we induced
bone marrow-derived OP9 mesenchymal cells to differentiate into either
osteoblastic or adipocytic stroma, and then tested their capacity to serve
as surrogate HSC niches during in vitro hematopoietic culture in the absence
of exogenous growth factors. We found that the presence of bone marrow-derived
adipocytes suppresses the expansion of short-term hematopoietic progenitors
by at least two fold as measured by the number of CD45+ cells expanded,
the number of colony forming units and the competitive repopulation during
the first two months post-transplant. As an in vivo correlate, we compared
the hematopoietic activity within the bone marrow of the adipocyte-poor
thoracic vertebrae and the adipocyte rich proximal tail vertebrae, and
found that the percentage of HSCs, CMPs, GMPs and MEPs was decreased by
two fold as determined phenotypically by FACS and functionally by competitive
repopulation. Mechanistically, oligonuclotide expression microarrays and
conditioned media experiments suggested that the inhibition of the progenitor
compartment in adipocytic-rich environments is due to the loss of supportive
membrane-bound and soluble factors (Jagged, N-cadherin, SCF, Angiopoietin-1
and BMPs) in addition to the presence of an active inhibitor. Finally,
we found bone marrow adipocytes to accumulate in great numbers upon bone
marrow ablation, a process that is hindered in genetically adipocyte-deficient
mice. Since early BM transplant survival depends on the rapid accumulation
of short term hematopoietic progenitors, we were interested to know if
the absence of adipocytes in this context would foster faster recovery
in lethally irradiated mice. As predicted, leukocyte counts on the third
week post-transplant were 3-5 times higher on the recovering fatless mice.
Accordingly, the bone marrow from fatless mice contained double the amount
of CFUs, HSCs, CMPs, GMPs and MEPs on day 17 post-transplant than their
wildtype littermates. We therefore conclude that, as seen in vitro, the
presence of adipocytes in the recovering HSC niche is detrimental to the
rapid hematopoietic expansion required to reconstitute blood production.
We are currently examining the pharmacologic modulation of adipocyte formation
for its effects in BM transplantation.
|
|||||||||